Catalyst
Slingshot members are tracking this event:
Phase 3 overall survival data of CPX-351 for Secondary AML due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CPXX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 14, 2016
Occurred Source:
http://ir.celatorpharma.com/releasedetail.cfm?ReleaseID=960543
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Secondary Aml, Phase 3, Cpx-351, Vyxeos, Combiplex, Aacr-nci-eortc
